The virtual showroom will provide real-time construction updates, various specs, and services that its new super plant, Plant 4, will offer upon completion.
Samsung Biologics announced on Dec. 4, 2020 that it is launching a virtual showroom to showcase key features of its new super plant, Plant 4.
The virtual showroom will provide real-time construction updates, various specs, and services that the new plant will offer upon completion, while also allowing the company to connect with clients interested in the plant’s progression, a company press release said. Construction started on the new plant in November 2020, and it is expected to be the world’s largest and most innovative bio-manufacturing facility of its kind, the company said in its press release.
“Our new super plant and our virtual showroom are a direct response to an accelerated demand in the industry for both traditional and digitally enabled services. By leveraging the latest innovation, Plant 4 will provide easy and secure access to manufacturing and quality information whenever customers require it and deliver the highest levels of client satisfaction and regulatory compliance,” said Dr. Tae Han Kim, CEO of Samsung Biologics, in the press release. “Our Plant 4 Virtual Showroom also exemplifies Samsung Biologics’ latest efforts to lead the industry in the digital revolution for enhanced connectivity and agility in responding to our clients, partners, and shareholders.”
Source: Samsung
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.